Alpha Teknova (TKNO) Operating Income (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Operating Income came in at -$4.3 million in Q1 2026, up 13.42% year-on-year from -$3.8 million in Q1 2025, and up 6.75% on a QoQ basis from -$4.6 million in Q4 2025.
Alpha Teknova (TKNO) Operating Income (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Operating Income data on file, last reported at -$4.3 million in Q1 2026.
- On a quarterly basis, Operating Income rose 13.42% year-over-year to -$4.3 million in Q1 2026; TTM through Mar 2026 was -$16.3 million, a 29.47% increase from a year earlier, with the FY2025 full-year figure at -$17.0 million, up 35.07% from the prior year.
- Operating Income for Q1 2026 stood at -$4.3 million, up from -$4.6 million in the prior quarter.
- Over the last five years, Operating Income for TKNO reached as high as -$3.4 million in Q2 2025 and fell as low as -$23.0 million in Q3 2022.
- Historically, Operating Income has averaged -$7.8 million across 5 years, with a median of -$6.6 million in 2022.
- Across the five-year window, Operating Income sank 605.68% in 2022 and surged 61.83% in 2023, its largest moves.
- Year by year, Operating Income stood at -$14.2 million in 2022, then rose by 23.73% to -$10.9 million in 2023, then jumped by 48.17% to -$5.6 million in 2024, then grew by 18.11% to -$4.6 million in 2025, then rose by 6.75% to -$4.3 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$4.3 million in Q1 2026, -$4.6 million in Q4 2025, and -$4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | -4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.30 Mn |
| Dec 31, 2025 | -4.61 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | -3.39 Mn |
| Mar 31, 2025 | -4.96 Mn |
| Dec 31, 2024 | -5.63 Mn |
| Sep 30, 2024 | -7.43 Mn |
| Jun 30, 2024 | -5.10 Mn |
| Mar 31, 2024 | -7.99 Mn |
| Dec 31, 2023 | -10.86 Mn |
| Sep 30, 2023 | -8.76 Mn |
| Jun 30, 2023 | -7.00 Mn |
| Mar 31, 2023 | -8.95 Mn |
| Dec 31, 2022 | -14.24 Mn |
| Sep 30, 2022 | -22.95 Mn |
| Jun 30, 2022 | -6.63 Mn |
| Mar 31, 2022 | -5.84 Mn |
| Dec 31, 2021 | -4.77 Mn |
| Sep 30, 2021 | -3.89 Mn |
| Jun 30, 2021 | -2.53 Mn |